Indegene Limited logo

INDGN.NS Earnings — Indegene Limited

NSE

Updated

Price —
Market Cap $143.0B
P/E 35.9
52W Range — – —

When is INDGN.NS's next earnings date?

Indegene Limited (INDGN.NS) has not announced its next earnings date yet. Its most recent earnings report was on Friday, October 30, 2026.

How did INDGN.NS do in its last earnings report?

In its most recent report on Oct 30, 2026, Indegene Limited posted EPS of $4.66 versus the $4.73 estimate, a miss of 1.5%. Revenue was $10.96B against a $11.04B estimate.

How much does INDGN.NS stock move after earnings?

INDGN.NS beat EPS estimates in 1 of its last 2 reported quarters.

About Indegene Limited

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

🤖 AI Earnings Analysis

INDGN.NS trades at 35.9× earnings with an 11.4% profit margin; without recent news or growth guidance, that valuation leaves limited evidence of a near-term catalyst.

AI-generated summary — powered by BigEarnings.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-10-304.734.66-1.48%$10.96B❌ Miss———
2026-07-304.634.83—$10.70B✅ Beat———

Showing last 2 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .